Home LiteratureArticle Details
PMID: 2905367 Published · ppublish English Journal Article Review

Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Journal of endocrinological investigation ·Vol. 11 ·No. 6 ·1988-06-00 ·Pages 441-62

Delitala G, Tomasi P, Virdis R

Abstract

暂无摘要

MeSH Terms
Feedback Growth Hormone/metabolism Growth Hormone-Releasing Hormone/physiology Humans Neuropeptides/physiology,therapeutic use Neurosecretory Systems/physiology Neurotransmitter Agents/physiology,therapeutic use Somatostatin/physiology
Chemicals
Neuropeptides Neurotransmitter Agents Somatostatin Growth Hormone Growth Hormone-Releasing Hormone
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Delitala G
Istituto di Endocrinologia ed Ematologia, Università di Sassari, Italy.
Tomasi P
Virdis R
References (169)
169 references, click to expand
  1. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.
    J Clin Invest. 1985 May;75(5):1584-90 PMID: 2860126
  2. Stimulation of human-growth-hormone secretion by L-dopa.
    N Engl J Med. 1970 Dec 24;283(26):1425-9 PMID: 5481776
  3. Adrenergic blockade and the corticosteroid and growth hormone responses to methylamphetamine.
    Nature. 1970 Nov 7;228(5271):565-6 PMID: 4394360
  4. Growth hormone releasing factor (hpGRF)-stimulation test in normal controls and acromegalic patients.
    J Endocrinol Invest. 1984 Jun;7(3):185-91 PMID: 6432889
  5. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    N Engl J Med. 1974 Apr 25;290(17):935-8 PMID: 4593614
  6. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.
    J Clin Endocrinol Metab. 1975 Aug;41(2):408-11 PMID: 239963
  7. Binding sites for growth hormone releasing factor on rat anterior pituitary cells.
    Nature. 1985 Feb 7-13;313(6002):487-9 PMID: 2982107
  8. The effect of adrenergic receptor blockade on the exercise-induced serum growth hormone rise in normals and juvenile diabetics.
    J Clin Endocrinol Metab. 1971 Nov;33(5):807-12 PMID: 4399438
  9. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995.
    J Clin Endocrinol Metab. 1988 Jan;66(1):16-23 PMID: 2891720
  10. Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.
    J Clin Endocrinol Metab. 1977 Sep;45(3):588-93 PMID: 302840
  11. Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone release.
    J Endocrinol. 1986 Jan;108(1):25-9 PMID: 2868066
  12. Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum.
    J Clin Endocrinol Metab. 1973 Nov;37(5):719-24 PMID: 4749446
  13. Nocturnal pulsatile growth hormone releasing hormone treatment in growth hormone deficiency.
    Clin Endocrinol (Oxf). 1986 Jul;25(1):35-44 PMID: 3098459
  14. Diurnal administration of human growth hormone-releasing factor does not modify sleep and sleep-related growth hormone secretion in normal young men.
    Acta Endocrinol (Copenh). 1985 Oct;110(2):158-63 PMID: 3933234
  15. In vivo and in vitro effects of cholecystokinin on gonadotropin, prolactin, growth hormone and thyrotropin release in the rat.
    Brain Res. 1979 Aug 24;172(2):295-302 PMID: 466475
  16. Effect of hypothyroidism on pituitary cytoplasmic concentrations of messenger RNA encoding thyrotrophin beta and alpha subunits, prolactin and growth hormone.
    J Endocrinol. 1986 Jan;108(1):43-7 PMID: 2418144
  17. Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.
    J Clin Invest. 1984 Jul;74(1):96-103 PMID: 6429198
  18. In vivo and in vitro effects of cholecystokinin octapeptide on the release of growth hormone in rats.
    Horm Metab Res. 1984 Dec;16(12):626-30 PMID: 6151935
  19. Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency.
    J Clin Endocrinol Metab. 1986 Nov;63(5):1100-5 PMID: 3093519
  20. Effect of various adrenergic receptor stimulating and blocking agents on human growth hormone secretion.
    J Endocrinol. 1972 Aug;54(2):195-206 PMID: 4403626
  21. Influence of dopaminergic, adrenergic and cholinergic blockade and TRH administration on GH responses to GRF 1-29.
    Clin Endocrinol (Oxf). 1986 Mar;24(3):291-8 PMID: 2871952
  22. Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat.
    Endocrinology. 1984 Jun;114(6):2409-11 PMID: 6609812
  23. Suppression by thyrotropin-releasing hormone (TRH) of growth hormone release induced by arginine and insulin-induced hypoglycemia in man.
    J Clin Endocrinol Metab. 1976 Aug;43(2):453-6 PMID: 820711
  24. Bromocriptine treatment of acromegaly.
    Br Med J. 1975 Feb 8;1(5953):299-303 PMID: 1111790
  25. Somatostatin: electron microscope immunohistochemical localization in secretory neurons of rat hypothalamus.
    Science. 1977 Jun 24;196(4297):1469-70 PMID: 867046
  26. Growth hormone responses to continuous infusions of growth hormone-releasing hormone.
    J Clin Endocrinol Metab. 1985 Aug;61(2):223-8 PMID: 3924946
  27. Motilin: a novel growth hormone releasing agent.
    Brain Res Bull. 1984 Jan;12(1):57-62 PMID: 6424871
  28. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.
    J Clin Endocrinol Metab. 1986 Oct;63(4):872-8 PMID: 3091629
  29. Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist.
    J Clin Endocrinol Metab. 1984 Nov;59(5):1025-6 PMID: 6434584
  30. The regional distribution of somatostatin in the rat brain.
    Endocrinology. 1975 Jun;96(6):1456-61 PMID: 1126315
  31. Clonidine treatment for short stature.
    Lancet. 1987 May 30;1(8544):1226-30 PMID: 2884368
  32. Effects of obesity-inducing ventromedial hypothalamic lesions on pulsatile growth hormone and insulin secretion: evidence for the existence of a growth hormone-releasing factor.
    Endocrinology. 1983 Jan;112(1):212-9 PMID: 6128221
  33. Effect of the antihistaminic agents meclastine and dexchlorpheniramine on the response of human growth hormone to arginine infusion and insulin hypoglycemia.
    J Clin Endocrinol Metab. 1976 Sep;43(3):582-6 PMID: 956343
  34. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    J Clin Endocrinol Metab. 1984 Mar;58(3):419-25 PMID: 6420440
  35. The effects of growth hormone-releasing factor (GRF) and dopamine on growth hormone (GH) secretion in acromegaly.
    J Endocrinol Invest. 1985 Jun;8(3):203-6 PMID: 3928732
  36. Endogenous cholinergic modulation of growth-hormone secretion in normal and acromegalic humans.
    Metabolism. 1980 Aug;29(8):703-6 PMID: 7402075
  37. Treatment of growth-hormone deficiency with growth-hormone-releasing hormone.
    Lancet. 1987 Jan 3;1(8523):5-8 PMID: 2879138
  38. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    J Clin Endocrinol Metab. 1985 May;60(5):985-93 PMID: 2858494
  39. Comparative study of human fetal, normal adult, and somatotropic adenoma pituitary function in tissue culture.
    J Clin Endocrinol Metab. 1982 Jan;54(1):6-16 PMID: 6119321
  40. Growth hormone response to growth hormone-releasing hormone in normal and uraemic children. Comparison with hypoglycaemia following insulin administration.
    Acta Endocrinol (Copenh). 1987 Jan;114(1):5-11 PMID: 3101340
  41. The effect of oxandrolone on the growth hormone response to growth hormone releasing hormone in children with constitutional growth delay.
    Clin Endocrinol (Oxf). 1986 Aug;25(2):195-200 PMID: 3098462
  42. Regulatory peptides of the hypothalamus.
    Annu Rev Physiol. 1977;39:473-527 PMID: 15499
  43. Failure to respond to growth hormone releasing hormone (GHRH) in acromegaly due to a GHRH secreting pancreatic tumor: dynamics of multiple endocrine testing.
    J Clin Endocrinol Metab. 1985 Sep;61(3):585-7 PMID: 3926812
  44. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.
    J Clin Endocrinol Metab. 1973 Jun;36(6):1259-62 PMID: 4196265
  45. Long-term treatment of acromegaly with bromocriptine.
    Br Med J. 1977 Apr 2;1(6065):875-8 PMID: 576843
  46. Effects of some gamma-aminobutyric acid (GABA)-ergic drugs on the dopaminergic control of human growth hormone secretion.
    J Clin Endocrinol Metab. 1980 Jul;51(1):124-9 PMID: 6769935
  47. Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion.
    J Clin Endocrinol Metab. 1986 Sep;63(3):709-16 PMID: 3525601
  48. Participation of cholinergic muscarinic receptors in glucagon- and arginine-mediated growth hormone secretion in man.
    J Clin Endocrinol Metab. 1982 Dec;55(6):1231-3 PMID: 6897069
  49. Dose-response relationships for the effects of growth hormone-releasing factor-(1-44)-NH2 in young adult men and women.
    J Clin Endocrinol Metab. 1984 Aug;59(2):197-201 PMID: 6330151
  50. Characterization of high affinity receptors for insulin-like growth factors I and II on rat anterior pituitary cells.
    Endocrinology. 1984 May;114(5):1571-5 PMID: 6325123
  51. Cholinergic and histaminergic involvement in the growth hormone releasing effect of an enkephalin analog FK 33-824 in man.
    Psychopharmacology (Berl). 1983;80(2):120-4 PMID: 6308703
  52. Effective long-term treatment of acromegaly with a long-acting somatostatin analogue (SMS 201-995).
    Clin Endocrinol (Oxf). 1987 Jan;26(1):85-95 PMID: 2879656
  53. Opiate receptors modulate LHRH and SRIF release from mediobasal hypothalamic neurons.
    Neuroendocrinology. 1981 Mar;32(3):163-7 PMID: 6111762
  54. Growth hormone neurosecretory dysfunction.
    Clin Endocrinol Metab. 1986 Aug;15(3):537-90 PMID: 2429794
  55. Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor.
    Nature. 1983 Nov 3-9;306(5938):86-8 PMID: 6415488
  56. New evidence for growth hormone modulation by the alpha-adrenergic system in man.
    Metabolism. 1977 Nov;26(11):1225-30 PMID: 20551
  57. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature.
    J Clin Endocrinol Metab. 1984 Oct;59(4):580-6 PMID: 6434572
  58. Involvement of growth hormone-releasing factor in growth hormone secretion induced by gamma-aminobutyric acid in conscious rats.
    Endocrinology. 1985 Aug;117(2):787-9 PMID: 3926462
  59. Stimulatory effects of gamma-aminohydroxybutyric acid (GABOB) on growth hormone, prolactin and cortisol release in man.
    Horm Metab Res. 1980 Jan;12(1):31-4 PMID: 6244218
  60. Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man.
    Lancet. 1983 Jan 1;1(8314-5):24-8 PMID: 6129370
  61. Dopamine stimulates somatostatin release from perifused hypothalamic cells.
    Am J Physiol. 1983 Jun;244(6):E560-6 PMID: 6134472
  62. Stable reduction of plasma growth hormone (hGH) levels during chronic administration of 2-Br-alpha-ergocryptine (CB-154) in acromegalic patients.
    J Clin Endocrinol Metab. 1975 Apr;40(4):705-8 PMID: 1127079
  63. Plasma GH responses to GHRH and insulin-induced hypoglycemia in man.
    J Clin Endocrinol Metab. 1985 Jun;60(6):1265-7 PMID: 3923025
  64. Effects of growth hormone-releasing factor on growth hormone secretion in acromegaly.
    J Clin Endocrinol Metab. 1985 Feb;60(2):251-7 PMID: 3917454
  65. Dopaminergic modulation of arginine mediated growth hormone and prolactin release in man.
    Metabolism. 1981 Jul;30(7):649-53 PMID: 7242371
  66. Comparison of the distribution of dynorphin systems and enkephalin systems in brain.
    Science. 1982 Dec 10;218(4577):1134-6 PMID: 6128790
  67. Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man.
    Neuroendocrinology. 1984 Apr;38(4):302-8 PMID: 6374488
  68. Potent interaction between glucocorticoids and growth hormone-releasing factor in vivo.
    Science. 1983 Aug 5;221(4610):556-8 PMID: 6408735
  69. Stimulation of growth hormone release by vasoactive intestinal peptide and peptide PHI in rat anterior pituitary reaggregates. Permissive action of a glucocorticoid and inhibition by thyrotropin-releasing hormone.
    Neuroendocrinology. 1985 Jan;40(1):88-91 PMID: 3918279
  70. Additive effects of growth hormone releasing factor and insulin hypoglycaemia on growth hormone release in man.
    Clin Endocrinol (Oxf). 1987 May;26(5):589-95 PMID: 3117447
  71. Localization of GRF-like immunoreactive neurons in the rat brain.
    Peptides. 1983 Jul-Aug;4(4):521-4 PMID: 6417632
  72. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients.
    J Clin Endocrinol Metab. 1985 Jun;60(6):1161-5 PMID: 2860119
  73. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly.
    J Clin Endocrinol Metab. 1987 Mar;64(3):585-91 PMID: 3102543
  74. Growth hormone-releasing factor binding sites in rat anterior pituitary membrane homogenates: modulation by glucocorticoids.
    Endocrinology. 1985 Jul;117(1):424-6 PMID: 2988927
  75. Augmentation by propranolol of growth hormone-releasing hormone-(1-44)-NH2-induced growth hormone release in normal short and normal children.
    J Clin Endocrinol Metab. 1985 Aug;61(2):229-33 PMID: 2989315
  76. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour.
    Nature. 1982 Nov 18;300(5889):276-8 PMID: 6292724
  77. The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man.
    J Clin Endocrinol Metab. 1985 Feb;60(2):290-3 PMID: 3917457
  78. Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man.
    J Clin Endocrinol Metab. 1983 Dec;57(6):1145-9 PMID: 6688812
  79. The effect of administration of human growth hormone on the plasma growth hormone, cortisol, glucose, and free fatty acid response to insulin: evidence for growth hormone autoregulation in man.
    J Clin Invest. 1971 Apr;50(4):940-50 PMID: 4926262
  80. Oral clonidine-an effective growth hormone-releasing agent in prepubertal subjects.
    J Pediatr. 1982 May;100(5):710-4 PMID: 7040621
  81. Clonidine accelerates growth in children with impaired growth hormone secretion.
    Lancet. 1985 Jun 29;1(8444):1482-5 PMID: 2861413
  82. Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency.
    Pediatrics. 1985 Aug;76(2):274-9 PMID: 3927254
  83. Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man.
    Acta Endocrinol (Copenh). 1986 Sep;113(1):12-6 PMID: 3020850
  84. Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal men.
    J Clin Endocrinol Metab. 1985 Nov;61(5):846-50 PMID: 3930551
  85. Biosynthesis of immunoreactive somatostatin by hypothalamic neurons in culture.
    J Clin Invest. 1982 Nov;70(5):1101-9 PMID: 7130395
  86. Central distribution of opioid peptides.
    Br Med Bull. 1983 Jan;39(1):11-6 PMID: 6132647
  87. The effect of lisuride hydrogen maleate, an ergot derivative on anterior pituitary hormone secretion in man.
    Clin Endocrinol (Oxf). 1979 Jul;11(1):1-9 PMID: 117952
  88. Vasoactive intestinal peptide: evidence for a hypothalamic site of action to release growth hormone, luteinizing hormone, and prolactin in conscious ovariectomized rats.
    Endocrinology. 1979 Jan;104(1):53-7 PMID: 446354
  89. Pituitary somatostatin receptors: dissociation at the pituitary level of receptor affinity and biological activity for selective somatostatin analogs.
    Regul Pept. 1982 Aug;4(3):141-6 PMID: 6127756
  90. Somatostatinergic neurons in anterior hypothalamus: immunohistochemical localization.
    Endocrinology. 1976 Jan;98(1):255-8 PMID: 765116
  91. Abnormalities of growth hormone release in response to human pancreatic growth hormone releasing factor (GRF (1-44) ) in acromegaly and hypopituitarism.
    Br Med J (Clin Res Ed). 1983 May 28;286(6379):1687-91 PMID: 6405935
  92. High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25.
    Regul Pept. 1981 Jan;1(4):255-64 PMID: 6114516
  93. Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro.
    Endocrinology. 1983 Apr;112(4):1553-5 PMID: 6131812
  94. Human pancreatic growth hormone releasing hormone fails to stimulate human growth hormone both in Cushing's disease and in Cushing's syndrome due to adrenocortical adenoma.
    Clin Endocrinol (Oxf). 1986 Apr;24(4):401-7 PMID: 3091296
  95. The effects of intranasal insufflation of growth hormone releasing factor analogue GRF 1-29 NH2 on growth hormone secretion in children with short stature.
    Acta Endocrinol Suppl (Copenh). 1986;279:135-8 PMID: 2877535
  96. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro.
    Endocrinology. 1968 Oct;83(4):783-90 PMID: 4879544
  97. Slight effect of L-tryptophan on growth hormone release in normal human subjects.
    J Clin Endocrinol Metab. 1974 Jul;39(1):1-5 PMID: 4546052
  98. Disorders of prolactin and growth hormone secretion.
    Clin Endocrinol Metab. 1985 Feb;14(1):1-32 PMID: 3926353
  99. Effect of 5-hydroxytryptophan (5-HTP) on growth hormone and ACTH release in man.
    J Clin Endocrinol Metab. 1973 Jan;36(1):204-6 PMID: 4344307
  100. Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor.
    Endocrinology. 1982 Feb;110(2):540-50 PMID: 6120072
  101. Characterization of insulin-like growth factor receptors in rat anterior pituitary, hypothalamus, and brain.
    Endocrinology. 1984 Apr;114(4):1187-95 PMID: 6323133
  102. Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin.
    J Endocrinol. 1986 Nov;111(2):271-8 PMID: 2878963
  103. Brain opiates and neuroendocrine function.
    Clin Endocrinol Metab. 1983 Nov;12(3):725-46 PMID: 6323067
  104. Independent effects of growth hormone releasing factor on growth hormone release and gene transcription.
    Nature. 1985 Mar 21-27;314(6008):279-81 PMID: 2858817
  105. Characterization of pituitary membrane receptors for somatostatin in the rat.
    Endocrinology. 1982 Jun;110(6):2138-44 PMID: 6122562
  106. Somatostatin and growth hormone releasing factor: synthesis, location, metabolism and function.
    Clin Endocrinol Metab. 1983 Nov;12(3):469-507 PMID: 6142777
  107. Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration.
    Acta Endocrinol (Copenh). 1986 Apr;111(4):433-9 PMID: 2871684
  108. Effect of intraventricular injection of dopamine, noreprinephrine, acetylcholine, and 5-hydroxytryptamine on immunoreactive somatostatin release into rat hypophyseal portal blood.
    Endocrinology. 1979 Jun;104(6):1656-62 PMID: 446386
  109. Neuroendocrine effects of quipazine in man in health state or with neurological disorders.
    J Neural Transm. 1980;47(4):273-97 PMID: 6446595
  110. Growth hormone stimulates hypothalamic somatostatin.
    Life Sci. 1979 Apr 23;24(17):1589-93 PMID: 481092
  111. Growth hormone neurosecretory dysfunction. A treatable cause of short stature.
    JAMA. 1984 May 4;251(17):2223-30 PMID: 6708271
  112. The effects of cholinergic blockade on the growth hormone and prolactin response to insulin hypoglycaemia.
    Clin Endocrinol (Oxf). 1985 Jun;22(6):733-7 PMID: 3893805
  113. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly.
    Science. 1982 Nov 5;218(4572):585-7 PMID: 6812220
  114. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.
    J Clin Endocrinol Metab. 1985 Jan;60(1):48-52 PMID: 3917270
  115. Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion.
    Neuroendocrinology. 1983 Oct;37(4):275-9 PMID: 6633817
  116. Effects of a gamma aminobutyric acid (GABA) derivative, baclofen, on growth hormone and prolactin secretion in man.
    J Clin Endocrinol Metab. 1977 Sep;45(3):579-84 PMID: 903403
  117. Evidence that opiatergic and alpha-adrenergic mechanisms stimulate rat growth hormone release via growth hormone-releasing factor (GRF).
    Endocrinology. 1984 May;114(5):1950-2 PMID: 6325138
  118. Effects of a growth hormone releasing factor in man.
    J Clin Endocrinol Metab. 1983 Sep;57(3):674-6 PMID: 6409918
  119. Growth-hormone-releasing factor in growth hormone deficiency: demonstration of a hypothalamic defect in growth hormone release.
    Lancet. 1983 Jul 16;2(8342):137-8 PMID: 6134983
  120. The organization and some projections of cholinergic neurons of the mammalian forebrain.
    Brain Res. 1982 Nov;257(3):327-88 PMID: 6756546
  121. The effect of glucose and free fatty acids on growth hormone (GH)-releasing factor-mediated GH secretion in rats.
    Endocrinology. 1986 Jun;118(6):2390-4 PMID: 2870916
  122. Effect of acute and repeated administration of gamma aminobutyric acid (GABA) on growth hormone and prolactin secretion in man.
    Acta Endocrinol (Copenh). 1980 Feb;93(2):149-54 PMID: 7376786
  123. Synthesis and biological actions of prosomatostatin.
    Proc Natl Acad Sci U S A. 1980 Oct;77(10):6171-4 PMID: 6108563
  124. Dopamine inhibition of stimulated growth hormone secretion: evidence for dopaminergic modulation of insulin- and L-dopa-induced growth hormone secretion in man.
    J Clin Endocrinol Metab. 1979 Sep;49(3):326-30 PMID: 468965
  125. Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH deficiency.
    J Clin Endocrinol Metab. 1984 Jun;58(6):1043-9 PMID: 6427257
  126. Growth hormone releasing factor induces prolactin secretion in acromegalic patients but not in normal subjects.
    Acta Endocrinol (Copenh). 1985 Aug;109(4):467-73 PMID: 3929513
  127. Growth hormone-releasing hormone.
    Endocr Rev. 1986 Aug;7(3):223-53 PMID: 2874984
  128. Desensitization to growth hormone-releasing factor (GRF) is associated with down-regulation of GRF-binding sites.
    Endocrinology. 1986 May;118(5):2045-52 PMID: 3009146
  129. Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man.
    J Clin Endocrinol Metab. 1985 Feb;60(2):370-5 PMID: 3917460
  130. Methoscopolamine inhibition of sleep-related growth hormone secretion. Evidence for a cholinergic secretory mechanism.
    J Clin Invest. 1978 Jun;61(6):1683-90 PMID: 659621
  131. Gamma-amino-beta-hydroxy butyric acid stimulates prolactin and growth hormone release in normal women.
    J Clin Endocrinol Metab. 1978 Dec;47(6):1336-40 PMID: 263354
  132. Long-term treatment with 2-Br-alpha-ergocryptine in acromegaly.
    Acta Endocrinol (Copenh). 1977 Jun;85(2):235-48 PMID: 405832
  133. Topographical and ontogenetic study of the neurons producing growth hormone-releasing factor in human hypothalamus.
    Regul Pept. 1984 Jan;8(1):21-31 PMID: 6425993
  134. Growth hormone secretion dynamics in a patient with ectopic growth hormone-releasing factor production.
    Am J Med. 1985 Jul;79(1):135-8 PMID: 3925780
  135. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.
    N Engl J Med. 1985 Dec 19;313(25):1576-80 PMID: 2866445
  136. Plasma growth hormone response to synthetic GH-RH1-44 in 52 children and adults with growth hormone deficiency of various etiologies.
    Horm Res. 1985;22(1-2):24-31 PMID: 3928474
  137. Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegaly.
    J Clin Endocrinol Metab. 1986 Mar;62(3):601-4 PMID: 3080469
  138. Negative feedback suppression of sleep-related growth hormone secretion.
    J Clin Endocrinol Metab. 1983 Mar;56(3):486-8 PMID: 6822649
  139. Prolactin, growth hormone and thyrotropin-thyroid hormone secretion during stress states in man.
    Baillieres Clin Endocrinol Metab. 1987 May;1(2):391-414 PMID: 3327498
  140. Light- and electron-microscopic immunocytochemistry of glutamic acid decarboxylase (GAD) in the basal hypothalamus: morphological evidence for neuroendocrine gamma-aminobutyrate (GABA).
    Neuroscience. 1983 Jun;9(2):271-87 PMID: 6681257
  141. Acetylcholine inhibits the release of somatostatin from rat hypothalamus in vitro.
    Endocrinology. 1980 Jul;107(1):122-9 PMID: 6103801
  142. Influence of growth hormone (GH) on content of GH in the pituitaries of normal rats.
    Proc Soc Exp Biol Med. 1966 Apr;121(4):1114-7 PMID: 5937712
  143. Endogenous dopaminergic dysfunction: a novel form of human growth hormone deficiency and short stature.
    J Clin Endocrinol Metab. 1986 Mar;62(3):484-90 PMID: 3080463
  144. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly.
    J Clin Endocrinol Metab. 1984 Feb;58(2):250-4 PMID: 6141175
  145. Effect of propranolol on the response of serum growth hormone to glucagon.
    J Clin Endocrinol Metab. 1971 Apr;32(4):470-5 PMID: 5547268
  146. Opiate peptides control growth hormone through a cholinergic mechanism in man.
    Clin Endocrinol (Oxf). 1983 Apr;18(4):401-5 PMID: 6409456
  147. Ectopic growth hormone releasing factor stimulates growth hormone release from human somatotroph adenomas in vitro.
    J Clin Endocrinol Metab. 1983 Feb;56(2):417-9 PMID: 6130102
  148. Hormonal and metabolic responses to an enkephalin analogue in normal man.
    Lancet. 1978 Dec 9;2(8102):1225-7 PMID: 82735
  149. Somatostatin-28 is longer acting and more selective than somatostatin-14 on pituitary and pancreatic hormone release.
    Endocrinology. 1982 Jul;111(1):101-7 PMID: 6123428
  150. Stimulation of prolactin and growth hormone secretion by muscimol, a gamma-aminobutyric acid agonist.
    J Clin Endocrinol Metab. 1978 Dec;47(6):1348-51 PMID: 162520
  151. Hypothalamic growth hormone releasing factor deficiency following cranial irradiation.
    Clin Endocrinol (Oxf). 1984 Nov;21(5):483-8 PMID: 6437704
  152. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.
    Science. 1973 Jan 5;179(4068):77-9 PMID: 4682131
  153. Effects of hypothalmic implants of GH on anterior pituitary weight and GH concentration.
    Endocrinology. 1969 Oct;85(4):725-34 PMID: 4895996
  154. Thyrotropin-releasing hormone stimulates growth hormone release from the anterior pituitary of hypothyroid rats in vitro.
    Endocrinology. 1984 Apr;114(4):1344-51 PMID: 6423373
  155. Role of alpha 1- and alpha 2-adrenergic receptors in the growth hormone and prolactin response to insulin-induced hypoglycemia in man.
    Neuroendocrinology. 1984 Sep;39(3):275-80 PMID: 6095132
  156. Cloning and sequence analysis of cDNA for the precursor of human growth hormone-releasing factor, somatocrinin.
    Proc Natl Acad Sci U S A. 1983 Jul;80(14):4311-4 PMID: 6192430
  157. Motilin stimulates growth hormone release in vitro.
    Brain Res Bull. 1982 Feb;8(2):117-21 PMID: 6121613
  158. Pituitary somatostatin receptors. Characterization by binding with a nondegradable peptide analogue.
    J Biol Chem. 1982 Feb 10;257(3):1134-7 PMID: 6120162
  159. A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs.
    J Clin Endocrinol Metab. 1986 Jul;63(1):16-9 PMID: 2872225
  160. Changes in plasma growth hormone levels in normal and acromegalic subjects following administration of 2-bromo-alpha-ergocryptine.
    J Clin Endocrinol Metab. 1975 Mar;40(3):363-6 PMID: 1117050
  161. Effect of surgical isolation of the hypothalamus on its neurotransmitter content.
    Brain Res. 1976 Nov 26;117(2):287-95 PMID: 11035
  162. Stimulation by growth hormone of somatostatin release from the rat hypothalamus in vitro.
    Clin Endocrinol (Oxf). 1978 Dec;9(6):583-6 PMID: 747898
  163. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    J Clin Endocrinol Metab. 1986 Aug;63(2):475-80 PMID: 3088026
  164. Hypothalamic somatostatin mediates the suppression of growth hormone secretion by centrally administered thyrotropin-releasing hormone in conscious rats.
    Endocrinology. 1985 Sep;117(3):1139-44 PMID: 2862016
  165. Serotonin distribution in the nuclei of the rat hypothalamus and preoptic region.
    Brain Res. 1974 Aug 30;77(1):157-65 PMID: 4854251
  166. Piperidine enhances sleep-related and insulin-induced growth hormone secretion: further evidence for a cholinergic secretory mechanism.
    J Clin Endocrinol Metab. 1981 Mar;52(3):409-15 PMID: 7007406
  167. Growth hormone neuroregulation and its alterations in disease states.
    Clin Endocrinol (Oxf). 1988 Jan;28(1):109-43 PMID: 2901921
  168. Catecholamine involvement in the control of growth hormone secretion in the domestic fowl.
    Gen Comp Endocrinol. 1984 Jun;54(3):360-71 PMID: 6735152
  169. Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF).
    Endocrinology. 1982 Dec;111(6):2147-8 PMID: 6128220
Article Info
Journal
Journal of endocrinological investigation
Abbr.
J Endocrinol Invest
ISSN
0391-4097
DOI
10.1007/BF03349081
Published
1988-06-00
Pages
441-62
Language
English
Region
Italy
NLM ID
7806594
Subset
IM
External Links
PubMed source DOI: 10.1007/BF03349081 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2